{"disease":{"id":"metastases-cns","name":"metastases cns"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05270707","title":"HyperArc Registry Study","phase":"","overall_status":"COMPLETED","enrollment_count":968,"lead_sponsor_name":"Varian, a Siemens Healthineers Company","has_results":false},{"nct_id":"NCT07227610","title":"Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":54,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT06322342","title":"Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reveal Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT03537911","title":"Cognitive Support Program for Patients With Brain Metastases","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04512261","title":"TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Reva Basho","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}